InvestorsHub Logo
Followers 72
Posts 6896
Boards Moderated 0
Alias Born 12/07/2011

Re: None

Saturday, 01/20/2018 2:17:38 PM

Saturday, January 20, 2018 2:17:38 PM

Post# of 402713
Great post from PP on valuation for B-OM alone:
—————————————-
“I just did a screen on common US stock (no ADRs):

Industry: Biotech and Pharma
Revenue TTM: 100M to 2000M
Revenue Growth TMM over TTM: < 200 %, to cut off cos having a insane revenue jump TTM over TTM

Surprise: Average price to sales ratio still about 9 and average revenue growth 23 %.

Apply that to future IPIX with 1 B$ revenue from one drug with growth potential in excess of 23 % year over year, which IPIX should be able to achieve easily with the rest of its pipeline. You get potential (and conservative) market cap 9 billion. Let's assume 200 million share (now about 140 million).

That gives for potential (and conservative) share price 9000/200 = 45 bucks.

Version 2: Assume 15 % royalty income. That is 150 million. But this income goes directly to earnings (no cost of goods etc). Can't use price to sales ratio because it does not apply here. Must use P/E for 75 cent per share earnings. Screen gave average P/E 50.

That gives future IPIX (conservative) share price of 37.5 USD.”
—————————————-

This puppy will go much much higher imo.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News